Help for this page

Journal of Basic and Applied Sciences Volume 1 (2026) · Issue 1

Original Research

CRISPR-Cas System: Reversing Antibiotic Resistance in Bacteria

Omega M. Immanuel*, Atamobebhu I. Isaiah

  1. * Corresponding author

Read PDFDownload PDF (526 KB)

Abstract

Antibiotic-resistant bacteria are a phenomenon threatening the efficacy of antimicrobial therapy in modern medicine. To tackle this public health menace, attention is shifting to the inclusion of a genetic approach to fight antimicrobial resistance (AMR), with the target being to effectively alter the genes that confer resistance on bacteria. The use of the Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) and its associated protein (Cas) holds promise as a genetic technology that can help tackle resistance in bacteria by directly targeting and incapacitating resistance genes or inducing lethal DNA breaks. This review x-rays antibiotic resistance as a menace to modern medicine, surveys the CRISPR system, explains the application for the treatment of infectious diseases, and identifies current challenges, limitations, and future directions for translating the technology into clinical practice. This technology has potential for use in the selective elimination of resistant pathogens, elimination of plasmids harbouring resistance genes, and resensitization of resistant pathogens. Modern medicine urgently needs to adopt this technology to combat antibioticresistant infectious diseases. However, with delivery efficiency, off-target effects, immunogenicity, and ethical governance must first be tackled before implantation succeeds.

Keywords

How to cite

Immanuel, O. M., & Isaiah, A. I. (2026). CRISPR-Cas System: Reversing Antibiotic Resistance in Bacteria. Journal of Basic and Applied Sciences, 1(1), Article JBAS-2026-0708-6F07B5. https://journals.uat.edu.ng/pub/0000000045
Immanuel, Omega M., and Atamobebhu I. Isaiah. "CRISPR-Cas System: Reversing Antibiotic Resistance in Bacteria." Journal of Basic and Applied Sciences, vol. 1, no. 1, 2026, article JBAS-2026-0708-6F07B5, https://journals.uat.edu.ng/pub/0000000045.
Immanuel, Omega M. and Atamobebhu I. Isaiah. 2026. "CRISPR-Cas System: Reversing Antibiotic Resistance in Bacteria." Journal of Basic and Applied Sciences 1 (1): JBAS-2026-0708-6F07B5. https://journals.uat.edu.ng/pub/0000000045.
Immanuel, O. M. and Isaiah, A. I. (2026) 'CRISPR-Cas System: Reversing Antibiotic Resistance in Bacteria', Journal of Basic and Applied Sciences, 1(1), Article JBAS-2026-0708-6F07B5. Available at: https://journals.uat.edu.ng/pub/0000000045 (Accessed: 20 November 2026).
O. M. Immanuel and A. I. Isaiah, "CRISPR-Cas System: Reversing Antibiotic Resistance in Bacteria," Journal of Basic and Applied Sciences, vol. 1, no. 1, Art. no. JBAS-2026-0708-6F07B5, 2026. [Online]. Available: https://journals.uat.edu.ng/pub/0000000045
BibTeX and RIS

BibTeX

@article{immanuel2026crisprcas,
  author = {Immanuel, Omega M. and Isaiah, Atamobebhu I.},
  title = {{CRISPR-Cas System: Reversing Antibiotic Resistance in Bacteria}},
  journal = {Journal of Basic and Applied Sciences},
  year = {2026},
  volume = {1},
  number = {1},
  note = {Article JBAS-2026-0708-6F07B5},
  publisher = {University of Africa, Toru-Orua},
  url = {https://journals.uat.edu.ng/pub/0000000045},
  keywords = {Antimicrobial therapy, CRISPR-Cas, drug-resistant bacteria, gene editing}
}

Download .bib

RIS

TY  - JOUR
AU  - Immanuel, Omega M.
AU  - Isaiah, Atamobebhu I.
TI  - CRISPR-Cas System: Reversing Antibiotic Resistance in Bacteria
JO  - Journal of Basic and Applied Sciences
PY  - 2026
DA  - 2026/07/08
VL  - 1
IS  - 1
C7  - JBAS-2026-0708-6F07B5
PB  - University of Africa, Toru-Orua
AB  - Antibiotic-resistant bacteria are a phenomenon threatening the efficacy of antimicrobial therapy in modern medicine. To tackle this public health menace, attention is shifting to the inclusion of a genetic approach to fight antimicrobial resistance (AMR), with the target being to effectively alter the genes that confer resistance on bacteria. The use of the Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) and its associated protein (Cas) holds promise as a genetic technology that can help tackle resistance in bacteria by directly targeting and incapacitating resistance genes or inducing lethal DNA breaks. This review x-rays antibiotic resistance as a menace to modern medicine, surveys the CRISPR system, explains the application for the treatment of infectious diseases, and identifies current challenges, limitations, and future directions for translating the technology into clinical practice. This technology has potential for use in the selective elimination of resistant pathogens, elimination of plasmids harbouring resistance genes, and resensitization of resistant pathogens. Modern medicine urgently needs to adopt this technology to combat antibioticresistant infectious diseases. However, with delivery efficiency, off-target effects, immunogenicity, and ethical governance must first be tackled before implantation succeeds.
KW  - Antimicrobial therapy
KW  - CRISPR-Cas
KW  - drug-resistant bacteria
KW  - gene editing
UR  - https://journals.uat.edu.ng/pub/0000000045
ER  - 

Download .ris